NCT04522921

Brief Summary

The main purpose of the present study is to perform a 10 weeks dietary intervention study with a follow-up for 52 weeks in children from 7-14 years of age with overweight or obesity. In a caloric restricted and increased physical activity setting the control group will consume a low-moderate protein (15E%/day) diet whereas the intervention group will consume a higher protein (25E%/day) diet. Secondary, the investigators want to investigate the effect of frequent follow-up after the intervention, and the overall effect of the lifestyle camp. Compared to the low-moderate protein diet, the investigators hypothesis that a diet with higher consumption of protein-containing foods will more effectively induce weight loss (a reduction in BMI-SDS) or weight maintenance in children with overweight or obesity, and improve quality of life, and risk factors for type 2 diabetes.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
211

participants targeted

Target at P75+ for not_applicable

Timeline
81mo left

Started Oct 2020

Longer than P75 for not_applicable

Geographic Reach
1 country

2 active sites

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress46%
Oct 2020Dec 2032

First Submitted

Initial submission to the registry

August 13, 2020

Completed
8 days until next milestone

First Posted

Study publicly available on registry

August 21, 2020

Completed
1 month until next milestone

Study Start

First participant enrolled

October 1, 2020

Completed
2.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2023

Completed
2.1 years until next milestone

Results Posted

Study results publicly available

August 22, 2025

Completed
7.4 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2032

Expected
Last Updated

April 29, 2026

Status Verified

April 1, 2026

Enrollment Period

2.7 years

First QC Date

August 13, 2020

Results QC Date

July 3, 2024

Last Update Submit

April 28, 2026

Conditions

Keywords

Eating BehaviorEating HabitQuality of LifeDietary HabitsEating Disorders

Outcome Measures

Primary Outcomes (4)

  • Body Mass Index Standard Deviation Score (BMI-SDS)

    BMI-SDS was calculated using World Health Organization Anthro-Plus software.

    Mean changes from baseline to 10-weeks (post camp intervention)

  • Body Weight (kg)

    Body weight (kg) was measured in light clothing without shoes using a Bioelectric impedance (InBody model 270, Hopkins Medical Products, Grand Rapids, MI, USA).

    Mean changes from baseline to 10-weeks (post camp intervention)

  • Body Fat (%)

    Body fat (%) was measured in light clothing without shoes using a Bioelectric impedance (InBody model 270, Hopkins Medical Products, Grand Rapids, MI, USA).

    Mean changes from baseline to 10-weeks (post camp intervention)

  • Skeletal Muscle Mass (kg)

    Skeletal muscle mass (kg) was measured in light clothing without shoes using a Bioelectric impedance (InBody model 270, Hopkins Medical Products, Grand Rapids, MI, USA).

    Mean changes from baseline to 10-weeks (post camp intervention)

Secondary Outcomes (17)

  • Body Height (m)

    Mean changes from baseline to 10-weeks (post camp intervention)

  • Systolic Blood Pressure

    Mean changes from baseline to 10-weeks (post camp intervention)

  • Diastolic Blood Pressure

    Mean changes from baseline to 10-weeks (post camp intervention)

  • P-cholesterol

    Mean changes from baseline to 10-weeks (post camp intervention)

  • HDL Cholesterol

    Mean changes from baseline to 10-weeks (post camp intervention)

  • +12 more secondary outcomes

Study Arms (3)

SARS CoV-group

OTHER

This group should have been the control group. However, due to the COVID19 lockdown of the camps for 5 five weeks, with no control of diet and physical activity, this group could not act as control group. Therefore, this group has been excluded from longitudinal analyses.

Dietary Supplement: Diet with a lower amount of protein (15E% per day)

Control Group (CG)

ACTIVE COMPARATOR

Current weight-loss diet (15E%/day protein) for the 10 weeks they attend the camp. Increased follow-up contact after camp.

Behavioral: Increased follow-up contact after the 10-week interventionDietary Supplement: Diet with a lower amount of protein (15E% per day)

Intervention group (IG)

EXPERIMENTAL

A higher protein diet (25E%/day) for the 10 weeks they attend the camp. Increased follow-up contact after camp.

Dietary Supplement: Diet with a higher amount of protein (25E% per day)Behavioral: Increased follow-up contact after the 10-week intervention

Interventions

In a caloric restricted and increased physical activity setting, the participants will be served a higher protein (25E%/day) diet.

Intervention group (IG)

Both the control-group and the intervention-group were offered an increased follow-up contact after camp.

Control Group (CG)Intervention group (IG)

In a caloric restricted and increased physical activity setting, the participants will be served a low-moderate protein (15E%/day) diet.

Control Group (CG)SARS CoV-group

Eligibility Criteria

Age7 Years - 14 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • The child attends a multi-component-overnight camp in Hobro or Fjordmark between October 2020 and March 2022.
  • The child is between 7 and 14 years of age (inclusive) while attending camp.
  • At least one parent/guardian submit written and oral consent to participate with his/her child.
  • Parent/legal guardian has submitted oral and written consent to participation of their child. In case of shared custody both parents must submit written and oral consent before their child can participate in the trial.

You may not qualify if:

  • The child has a disease, diagnose or eating disorder that require treatment.
  • The child or parent/guardian participate in another clinical trial or plan to do so in the near future.
  • The parent/guardian do not understand the written informed consent.
  • The child or parent/guardian are unwilling to or unable to comply with the study protocol and instruction given by the study staff.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Weight Loss Camp Hobro

Hobro, 9500, Denmark

Location

Weight Loss Camp Fjordmark

KrusÄ, 6340, Denmark

Location

Related Publications (5)

  • Jakobsen DD, Brader L, Bruun JM. Effect of a higher protein diet and lifestyle camp intervention on childhood obesity (The COPE study): results from a nonrandomized controlled trail with 52-weeks follow-up. Eur J Nutr. 2024 Sep;63(6):2173-2184. doi: 10.1007/s00394-024-03420-z. Epub 2024 May 9.

  • Jakobsen DD, Jarvholm K, Brader L, Bruun JM. Long-term changes in eating-related problems and quality of life in children with overweight and obesity attending a 10-week lifestyle camp. Obes Res Clin Pract. 2024 May-Jun;18(3):209-215. doi: 10.1016/j.orcp.2024.04.002. Epub 2024 May 4.

  • Pauls DD, Clausen L, Bruun JM. Eating behavior profiles in children following a 10-week lifestyle camp due to overweight/obesity and low quality of life: A latent profile analysis on eating behavior. Eat Behav. 2025 Apr;57:101971. doi: 10.1016/j.eatbeh.2025.101971. Epub 2025 Mar 24.

  • Aagaard I, Jakobsen DD, Bruun JM. Association between quality of life and emotional overeating - a cross-sectional study in Danish children attending a multicomponent lifestyle camp. Eur J Pediatr. 2023 Dec;182(12):5493-5499. doi: 10.1007/s00431-023-05206-7. Epub 2023 Sep 30.

  • Orry S, Dalstrup Jakobsen D, Kristensen NM, Meldgaard Bruun J. Uric acid and sCD163 as biomarkers for metabolic dysfunction and MAFLD in children and adolescents with overweight and obesity. J Pediatr Endocrinol Metab. 2023 Jun 8;36(7):643-649. doi: 10.1515/jpem-2023-0228. Print 2023 Jul 26.

MeSH Terms

Conditions

Pediatric ObesityOverweightObesityDiabetes MellitusFeeding BehaviorFeeding and Eating Disorders

Interventions

DietMethods

Condition Hierarchy (Ancestors)

OvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and SymptomsGlucose Metabolism DisordersMetabolic DiseasesEndocrine System DiseasesBehavior, AnimalBehaviorSigns and Symptoms, DigestiveMental Disorders

Intervention Hierarchy (Ancestors)

Nutritional Physiological PhenomenaDiet, Food, and NutritionPhysiological PhenomenaInvestigative Techniques

Results Point of Contact

Title
Dorthe Dalstrup Pauls
Organization
Department of Clinical Medicine, Aarhus University / Steno Diabetes Center Aarhus, Aarhus University Hospital

Study Officials

  • Jens M Bruun, Professor

    Aarhus University Hospital

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Masking Details
At enrollment the participants have no knowledge of which group they are assigned. The investigator has no knowledge of or influence on how participants are divided into different groups. Participants are assigned groups by the camp staff.
Purpose
PREVENTION
Intervention Model
FACTORIAL
Model Details: 1. SARS CoV group (former control group): Current weight-loss diet (15E%/day protein) for the 10 weeks they attend the camp, however, due to a COVID19 lockdown of the camps, these children were sent home for five weeks, and therefore excluded from longitudinal comparison between the groups. 2. Control group (CG): Current weight-loss diet (15E%/day protein) for the 10 weeks they attend the camp. 2\) Intervention group (IG): A higher protein diet (25E%/day) for the 10 weeks they attend the camp.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 13, 2020

First Posted

August 21, 2020

Study Start

October 1, 2020

Primary Completion

June 30, 2023

Study Completion (Estimated)

December 31, 2032

Last Updated

April 29, 2026

Results First Posted

August 22, 2025

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will not share

Locations